Alam J, Sabbagh MN. Perspective: Minimally clinically important "symptomatic" benefit associated with disease modification resulting from anti-amyloid immunotherapy. Alzheimers Dement (N Y). 2025;11(1):e70035. Epub 2025 Jan 20 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.